Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ), has responded to the release of the Sherrill Administration’s Economic Development and Innovation Report. In a statement issued on February 18, Buteas expressed support for the administration’s efforts.
“We are excited to work with Governor Sherrill and her team to protect New Jersey’s status as the ‘Medicine Chest of the World’ and preserve our long-standing global leadership in innovation,” Buteas said.
She emphasized the importance of improving New Jersey’s business environment as life sciences companies relocate research and manufacturing operations to the United States. “It is imperative that New Jersey make its business environment more hospitable to attract these new facilities, the billions of dollars in construction activity and the resulting direct and indirect jobs they bring. This requires a command focus addressing our tax structure, our regulatory hurdles and additional business environment challenges. The Sherrill Administration has made some critical and long-overdue policy recommendations to strengthen New Jersey’s workforce and economy, proposals that – if enacted – would vastly improve our state’s business climate, modernize our economy and create high-quality, high-paying jobs in the long-term.”
Buteas concluded by recognizing Governor Sherrill’s approach: “We applaud the urgency with which the Governor has worked to address this situation, and we thank her for her continued focus on strengthening our state’s innovation economy. We will continue working with her Administration to implement these thoughtful and strategic policies that will continue improving New Jersey’s global reputation.”
The HealthCare Institute of New Jersey is a nonprofit trade association based in Princeton that represents companies in biopharmaceuticals and medical technology. It advocates for public health education, supports biopharmaceutical progress, promotes patient access, economic growth within life sciences, builds alliances for healthcare innovation, engages in policy advocacy at both state and federal levels, and highlights advances in medicines as well as contributions to New Jersey’s healthcare system (https://hinj.org/).
